Lymphoma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Lymphoma stocks.

Lymphoma Stocks Recent News

Date Stock Title
May 3 ALRN Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million
May 3 CRDF Cardiff Oncology, Inc. (CRDF) Q1 2023 Earnings Call Transcript
May 2 CRDF Cardiff Oncology GAAP EPS of -$0.22 beats by $0.03, revenue of $0.2M beats by $0.14M
May 2 CRDF Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
May 2 BIIB Biogen Reports Progress on Corporate Responsibility Priorities
May 2 ALRN Aileron reports data from Cohort 1 of Phase Ib inhaled IPF treatment trial
May 1 CRDF Cardiff Oncology Q1 2024 Earnings Preview
May 1 BGNE BeiGene, AbbVie patent spat to get trial from USPTO appeals board
May 1 BPTH Looking Into Bio-Path Hldgs's Recent Short Interest
May 1 BIIB Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
May 1 ALRN Aileron announces pricing of underwritten registered direct offering priced at-the-market under Nasdaq rules of up to about $40M
May 1 ALRN Aileron Therapeutics announces positive data from its early stage pulmonary fibrosis treatment trial
May 1 ALRN Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million
May 1 ALRN Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
May 1 AEZS Aeterna Zentaris Announces Effective Date of Share Consolidation
Apr 30 BIIB Biogen: Reasons To Be Cheerful After Upbeat Q1 Earnings
Apr 30 BIIB Biogen: Don't Overthink This One
Apr 30 CERO CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes
Apr 30 CRIS Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
Apr 29 BIIB The Analyst Landscape: 27 Takes On Biogen
Lymphoma

Lymphoma is a group of blood cancers that develop from lymphocytes (a type of white blood cell). The name often refers to just the cancerous versions rather than all such tumors. Signs and symptoms may include enlarged lymph nodes, fever, drenching sweats, unintended weight loss, itching, and constantly feeling tired. The enlarged lymph nodes are usually painless. The sweats are most common at night.There are dozens of subtypes of lymphomas. The two main categories of lymphomas are Hodgkin's lymphomas (HL) and the non-Hodgkin lymphomas (NHL). The World Health Organization (WHO) includes two other categories as types of lymphoma: multiple myeloma and immunoproliferative diseases. About 90% of lymphomas are non-Hodgkin lymphomas. Lymphomas and leukemias are a part of the broader group of tumors of the hematopoietic and lymphoid tissues.Risk factors for Hodgkin lymphoma include infection with Epstein–Barr virus and a history of the disease in the family. Risk factors for common types of non-Hodgkin lymphomas include autoimmune diseases, HIV/AIDS, infection with human T-lymphotropic virus, immunosuppressant medications, and some pesticides. Eating large amounts of red meat and tobacco smoking may also increase the risk. Diagnosis, if enlarged lymph nodes are present, is usually by lymph node biopsy. Blood, urine, and bone marrow testing may also be useful in the diagnosis. Medical imaging may then be done to determine if and where the cancer has spread. Lymphoma most often spreads to the lungs, liver, and brain.

Browse All Tags